Hefei Lifeon Pharmaceutical Co Ltd (003020) — Cash Flow-to-Debt Ratio
Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Cash Flow-to-Debt Ratio of 1.02x as of September 2025, meaning its operating cash flow of CN¥667.63 Million could theoretically repay 1% of its total liabilities (CN¥652.24 Million) in one year. Check Hefei Lifeon Pharmaceutical Co Ltd (003020) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hefei Lifeon Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Hefei Lifeon Pharmaceutical Co Ltd across 13 annual periods. Also explore 003020 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)
Year-by-year debt coverage analysis for Hefei Lifeon Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Hefei Lifeon Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥212.89 Million | CN¥634.19 Million | ▲ +14.4% |
| 2024 | 0.29x | CN¥197.53 Million | CN¥673.38 Million | ▼ -12.1% |
| 2023 | 0.33x | CN¥203.67 Million | CN¥610.18 Million | ▲ +6.7% |
| 2022 | 0.31x | CN¥200.64 Million | CN¥641.53 Million | ▼ -27.0% |
| 2021 | 0.43x | CN¥158.70 Million | CN¥370.53 Million | ▼ -10.1% |
| 2020 | 0.48x | CN¥172.49 Million | CN¥362.03 Million | ▼ -4.3% |
| 2019 | 0.50x | CN¥149.30 Million | CN¥299.82 Million | ▲ +105.0% |
| 2018 | 0.24x | CN¥64.45 Million | CN¥265.31 Million | ▲ +438.8% |
| 2017 | 0.05x | CN¥11.32 Million | CN¥251.14 Million | ▼ -80.9% |
| 2016 | 0.24x | CN¥58.99 Million | CN¥249.71 Million | ▼ -33.2% |
| 2014 | 0.35x | CN¥92.05 Million | CN¥260.11 Million | ▲ +168.2% |
| 2013 | 0.13x | CN¥35.54 Million | CN¥269.34 Million | ▲ +459.3% |
| 2012 | -0.04x | CN¥-7.96 Million | CN¥216.67 Million | — |